Nicolaas Schaap

7.6k total citations
152 papers, 4.6k citations indexed

About

Nicolaas Schaap is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Nicolaas Schaap has authored 152 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 60 papers in Immunology and 40 papers in Oncology. Recurrent topics in Nicolaas Schaap's work include Hematopoietic Stem Cell Transplantation (64 papers), Immune Cell Function and Interaction (39 papers) and Acute Myeloid Leukemia Research (33 papers). Nicolaas Schaap is often cited by papers focused on Hematopoietic Stem Cell Transplantation (64 papers), Immune Cell Function and Interaction (39 papers) and Acute Myeloid Leukemia Research (33 papers). Nicolaas Schaap collaborates with scholars based in Netherlands, United States and France. Nicolaas Schaap's co-authors include Harry Dolstra, Willemijn Hobo, Robbert van der Voort, Frank Preijers, Jan Spanholtz, Joop H. Jansen, Frans Maas, Marleen Tordoir, Théo de Witte and Ruben A. Mesa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nicolaas Schaap

148 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolaas Schaap Netherlands 39 2.1k 1.9k 1.5k 1.0k 794 152 4.6k
Álvaro Urbano-Ispizúa Spain 44 3.3k 1.6× 2.3k 1.2× 1.7k 1.2× 819 0.8× 1.3k 1.6× 215 6.1k
Kenneth F. Bradstock Australia 37 2.3k 1.1× 1.3k 0.7× 1.3k 0.9× 1.4k 1.3× 682 0.9× 156 4.7k
A. John Barrett United States 43 3.9k 1.9× 2.7k 1.4× 1.7k 1.2× 824 0.8× 825 1.0× 109 6.0k
Peter Westervelt United States 39 3.2k 1.5× 1.4k 0.7× 1.4k 0.9× 1.8k 1.8× 638 0.8× 195 5.7k
G J Mufti United Kingdom 36 2.8k 1.3× 1.0k 0.5× 1.4k 1.0× 1.2k 1.2× 988 1.2× 119 4.8k
Koji Izutsu Japan 35 1.1k 0.5× 1.0k 0.5× 2.0k 1.4× 1.1k 1.1× 730 0.9× 265 4.6k
Lubomir Sokol United States 37 1.3k 0.6× 1.4k 0.7× 1.8k 1.3× 1.3k 1.3× 1.4k 1.8× 269 5.3k
Dirk Schwabe Germany 30 1.2k 0.6× 1.4k 0.7× 1.2k 0.9× 683 0.7× 356 0.4× 105 3.7k
Olivier Tournilhac France 36 1.5k 0.7× 1.6k 0.8× 1.5k 1.1× 584 0.6× 1.5k 1.9× 180 4.8k
S Slavin Israel 39 3.1k 1.4× 2.5k 1.3× 1.2k 0.8× 574 0.6× 682 0.9× 186 5.7k

Countries citing papers authored by Nicolaas Schaap

Since Specialization
Citations

This map shows the geographic impact of Nicolaas Schaap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolaas Schaap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolaas Schaap more than expected).

Fields of papers citing papers by Nicolaas Schaap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolaas Schaap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolaas Schaap. The network helps show where Nicolaas Schaap may publish in the future.

Co-authorship network of co-authors of Nicolaas Schaap

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolaas Schaap. A scholar is included among the top collaborators of Nicolaas Schaap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolaas Schaap. Nicolaas Schaap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wynn, Robert, Fernanda Volt, Philippe Guardiola, et al.. (2025). Impact of shared HLA determinants between patient and losing cord blood unit on relapse after double cord blood transplantation. Blood Advances. 9(17). 4425–4435. 2 indexed citations
2.
Evert, Janneke S. Hoogstad‐van, Paul K.J.D. de Jonge, Petra L.M. Zusterzeel, et al.. (2025). Intraperitoneal infusion of stem cell-derived natural killer cells in recurrent epithelial ovarian cancer patients: Results of the phase 1 INTRO-01 trial. Gynecologic Oncology. 204. 91–99. 1 indexed citations
3.
Renders, Simon, Hervé Finel, William Townsend, et al.. (2024). Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study. Blood Advances. 8(21). 5571–5578.
4.
Karron, Ruth A., Kimberli Wanionek, Alexander C. Schmidt, et al.. (2023). Evaluation of a Live-Attenuated Human Parainfluenza Virus Type 2 Vaccine in Adults and Children. Journal of the Pediatric Infectious Diseases Society. 12(3). 173–176. 3 indexed citations
5.
Brummelman, Jolanda, Dorette S. van Ingen Schenau, Mirjam H.M. Heemskerk, et al.. (2023). Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo. Cellular and Molecular Life Sciences. 80(10). 298–298. 2 indexed citations
6.
Loke, Justin, Myriam Labopin, Charles Craddock, et al.. (2022). Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia. Cancer. 128(15). 2922–2931. 31 indexed citations
7.
Thordardottir, Soley, Anniek B. van der Waart, J.H. Frederik Falkenburg, et al.. (2021). Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses. Cancer Immunology Immunotherapy. 70(11). 3167–3181. 16 indexed citations
8.
Velden, Walter J. F. M. van der, Joop H. Jansen, Brigitte Bär, et al.. (2021). Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 56(8). 1964–1970. 7 indexed citations
9.
Labopin, Myriam, Jordi Esteve, Nicolaus Kröger, et al.. (2021). Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT. Bone Marrow Transplantation. 56(10). 2445–2453. 8 indexed citations
10.
Jonge, Paul K.J.D. de, Anniek B. van der Waart, Jolanda Brummelman, et al.. (2021). CD34 + progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg null mice. OncoImmunology. 10(1). 1981049–1981049. 14 indexed citations
11.
Díaz‐Beyá, Marina, Myriam Labopin, Johan Maertens, et al.. (2020). Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK‐NUP214 shows a favourable outcome when performed in first complete remission. British Journal of Haematology. 189(5). 920–925. 14 indexed citations
12.
Harrison, Claire, Nicolaas Schaap, Alessandro M. Vannucchi, et al.. (2020). Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure. American Journal of Hematology. 95(6). 594–603. 104 indexed citations
13.
Evert, Janneke S. Hoogstad‐van, Alan J. Korman, Paul K.J.D. de Jonge, et al.. (2020). TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer. OncoImmunology. 9(1). 1843247–1843247. 54 indexed citations
14.
Waart, Anniek B. van der, Diana Campillo-Davó, Hanny Fredrix, et al.. (2020). PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity. Bone Marrow Transplantation. 55(12). 2308–2318. 15 indexed citations
15.
Poiré, Xavier, Myriam Labopin, Johan Maertens, et al.. (2016). Allogeneic stem cell transplantation in adult patients with acute myeloid leukemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European society of Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 51. 1 indexed citations
16.
Roeven, Mieke W.H., Soley Thordardottir, Frans Maas, et al.. (2015). The Aryl Hydrocarbon Receptor Antagonist StemRegenin1 Improves In Vitro Generation of Highly Functional Natural Killer Cells from CD34 + Hematopoietic Stem and Progenitor Cells. Stem Cells and Development. 24(24). 2886–2898. 31 indexed citations
17.
Berrevoets, Marvin A. H., Rachel S. van der Post, & Nicolaas Schaap. (2013). A patient with pure red cell aplasia after allogenic stem-cell transplantation. Parvo B19 infection.. PubMed. 71(7). 370, 374–370, 374. 3 indexed citations
18.
Norde, Wieger J., Frans Maas, Willemijn Hobo, et al.. (2011). PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation. Cancer Research. 71(15). 5111–5122. 126 indexed citations
19.
Schaap, Nicolaas, et al.. (2001). Chimerism patterns in subpopulations of PBMCs in stable mixed chimeras after T-cell depleted SCT. Bone Marrow Transplantation. 27.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026